-
-
-
-
-
-
-
OnKure Therapeutics (OKUR) Misses Q3 EPS by 109c
-
-
-
-
-
-
-
OnKure (OKUR) Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
-
-
-
417,356 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

